Chongqing Land Tower Pharmaceutical

Chongqing Land Tower Pharmaceutical, established in 2010, is a Chinese company specializing in the manufacturing of Active Pharmaceutical Ingredients (APIs) and intermediates. Located within the Changshou Chemical Industrial Zone of Chongqing, China, they operate under China's GMP (Good Manufacturing Practice) certification and have even passed a USFDA (United States Food and Drug Administration) site inspection. This highlights their commitment to international quality standards. Land Tower boasts a production capacity exceeding 500 tons of APIs annually, offering a range of products including Clindamycin HCL, Clindamycin Phosphate, Dibucaine, Naltrexone, and Methylnatrexone bromide. Their reach extends beyond China, supplying clients in various regions like North America, Europe, and Asia.